Optilene® Suture Material for Dermal Sutures (NCT05240248) | Clinical Trial Compass
CompletedNot Applicable
Optilene® Suture Material for Dermal Sutures
Spain172 participantsStarted 2022-06-22
Plain-language summary
In this non-interventional study, Optilene® suture will be evaluated for skin closure in adult patients.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients undergoing skin closure using Optilene® suture material.
* Small (0.5 cm - 10 cm) linear minimally contaminated incision/laceration in the trunk, neck or extremities (in the event that more than one incision is performed in the same patient, only one incision will be included).
* Written informed consent.
Exclusion Criteria:
* Emergency surgery.
* Transplant surgery.
* Pregnancy.
* Facial laceration or incision.
* Visible dirt in the wound.
* Non-linear shape.
* Patient with limb ischemia.
* Patient taking medication that might affect wound healing (i.e. cytotoxic antineoplastic and immunosuppressive agents, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants).
* Patient with hypersensitivity or allergy to the suture material.
What they're measuring
1
Surgical Site Infection Rate
Timeframe: at suture removal approximately 10±5 days postoperatively.